Daniel Lochner - 05 Feb 2025 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Feb 2025, 16:19:30 UTC
Prior SEC filing
06 Feb 2025
Next SEC filing
29 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Lochner

Key filing fact

Daniel Lochner filed Form 4 for Tectonic Therapeutic, Inc. (TECX) on 07 Feb 2025.

Key facts

  • This page summarizes Daniel Lochner's Form 4 filing for Tectonic Therapeutic, Inc. (TECX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Feb 2025, 16:19.

Change

  • Previous filing in this sequence was filed on 06 Feb 2025.
  • Current net transaction value: +$249,964.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECX transaction

Common Stock

Purchase

Transaction value
$249,964
Shares
+4,617
Change %
Price
$54.14
Shares after
4,617
Date
05 Feb 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .